1. Home
  2. PTCT vs CAAP Comparison

PTCT vs CAAP Comparison

Compare PTCT & CAAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

SELL

Current Price

$63.51

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Logo Corporacion America Airports SA

CAAP

Corporacion America Airports SA

SELL

Current Price

$24.65

Market Cap

4.5B

ML Signal

SELL

Company Overview

Basic Information
Metric
PTCT
CAAP
Founded
1998
1998
Country
United States
Luxembourg
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.5B
IPO Year
2006
2017

Fundamental Metrics

Financial Performance
Metric
PTCT
CAAP
Price
$63.51
$24.65
Analyst Decision
Buy
Buy
Analyst Count
14
6
Target Price
★ $101.07
$32.40
AVG Volume (30 Days)
★ 1.2M
295.0K
Earning Date
11-03-2026
11-23-2026
Dividend Yield
N/A
★ 7.42%
EPS Growth
★ 264.48
N/A
EPS
★ 0.90
N/A
Revenue
★ $264,734,000.00
N/A
Revenue This Year
N/A
$5.51
Revenue Next Year
$9.26
$9.22
P/E Ratio
$71.38
★ $26.35
Revenue Growth
★ 36.19
N/A
52 Week Low
$61.23
$17.51
52 Week High
$90.87
$30.50

Technical Indicators

Market Signals
Indicator
PTCT
CAAP
Relative Strength Index (RSI) 40.49 50.97
Support Level $62.46 $23.65
Resistance Level $72.86 $25.38
Average True Range (ATR) 2.00 0.82
MACD 0.19 -0.00
Stochastic Oscillator 38.57 43.13

Price Performance

Historical Comparison
PTCT
CAAP

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About CAAP Corporacion America Airports SA

Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.

Share on Social Networks: